HEAD AND NECK

Clinical trials for HEAD AND NECK explained in plain language.

Never miss a new study

Get alerted when new HEAD AND NECK trials appear

Sign up with your email to follow new studies for HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1

New drug EPI-326 enters human testing for tough cancers

Disease control Recruiting now

This early-stage study tests a new drug called EPI-326 in about 110 people with advanced lung cancer (with a specific EGFR gene change) or head and neck cancer. The main goal is to find a safe dose and check for side effects. Researchers will also measure drug levels in the blood…

Matched conditions: HEAD AND NECK

Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control

Last updated May 13, 2026 16:02 UTC

HEAD AND NECK

Get alerted when new HEAD AND NECK trials appear

New drug EPI-326 enters human testing for tough cancers